Clinical trial
Radiogenomics of Muscle Invasive Bladder Cancer
NCT04806334 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiogenomics of Muscle Invasive Bladder Cancer
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 2, 2021
- Completion date
- April 1, 2024
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer stage ii